Editing
Ai Clinical Trials
(section)
Jump to navigation
Jump to search
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
== <span style="color: #FFFFFF;">Remembering</span> == * '''Clinical trial phases''' β Phase I (safety, n=20-80), II (efficacy + safety, n=100-300), III (large-scale efficacy, n=1000+), IV (post-market surveillance). * '''Randomized Controlled Trial (RCT)''' β The gold standard: patients randomly assigned to treatment or control; eliminates selection bias. * '''Eligibility criteria''' β Inclusion/exclusion criteria defining who can participate; AI helps match patients to criteria automatically. * '''Patient recruitment''' β The most common cause of trial failure and delay; AI identifies eligible patients from EHR data. * '''Dropout / attrition''' β Patients withdrawing from trials; ML predicts which patients are at risk of dropout. * '''Adaptive trial design''' β Trial design that allows pre-specified modifications (dose, sample size, arms) based on interim data. * '''Basket trial''' β Tests a treatment in multiple diseases sharing a biomarker; requires sophisticated subgroup analysis. * '''Umbrella trial''' β Tests multiple treatments in one disease, matched to patient biomarkers; AI matches patients to arms. * '''Protocol deviation''' β Failure to follow trial protocol; NLP detects deviations in clinical notes. * '''Electronic data capture (EDC)''' β Digital systems for recording trial data; AI detects data quality issues. * '''Safety monitoring''' β Continuous surveillance for adverse events; ML detects safety signals before Data Safety Monitoring Board review. * '''Surrogate endpoint''' β A measurable outcome used as a proxy for clinical outcomes; AI identifies new surrogate biomarkers. * '''Historical data augmentation''' β Using historical control data to reduce the required control arm size (via Bayesian borrowing). * '''Synthetic control arm''' β Using ML on historical data to construct a virtual control arm, reducing need for placebo patients. * '''TrialSpark / Medidata / Veeva Vault''' β Commercial clinical trial AI platforms. </div> <div style="background-color: #006400; color: #FFFFFF; padding: 20px; border-radius: 8px; margin-bottom: 15px;">
Summary:
Please note that all contributions to BloomWiki may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
BloomWiki:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Navigation menu
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Namespaces
Page
Discussion
English
Views
Read
Edit
View history
More
Search
Navigation
Main page
Recent changes
Random page
Help about MediaWiki
Tools
What links here
Related changes
Special pages
Page information